Financials

  • Market Capitalization 152.11 M
  • Employee 91
  • Founded 1998
  • CEO N/A
  • Website www.maxcyte.com
  • Headquarter Delaware, United States
  • FIGI BBG00R1W85V4
  • Industry Medical Devices
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.69
Price to sales ratio
4.99

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3708
APYX
Apyx Medical Corporation - Common Stock
4.24 USD-0.47%+0.95%-11.11%+119.69%177.55 M USD
3729
INGN
Inogen, Inc - Common Stock
6.33 USD-3.21%-3.21%-1.86%-28.68%171.38 M USD
3849
CVRX
CVRx, Inc. - Common Stock
5.17 USD-4.79%-9.93%-1.34%-30.23%137.19 M USD
3891
RCEL
Avita Medical, Inc. - Common Stock
4.01 USD+1.52%-19.80%+1.52%-31.80%123.41 M USD

Frequently asked questions about MaxCyte, Inc. - Common Stock

What is the MaxCyte, Inc. - Common Stock stock price today?

The current price of MaxCyte, Inc. - Common Stock (MXCT) is 1.42. Over the past 24 hours, the stock has changed by +2.90%. Follow the MXCT chart for real-time price dynamics.

What is the stock ticker of MaxCyte, Inc. - Common Stock?

MaxCyte, Inc. - Common Stock trades under the ticker MXCT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is MaxCyte, Inc. - Common Stock stock going up?

MXCT has changed by +10.08% over the last week, +24.56% over the last month, and -37.17% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was MaxCyte, Inc. - Common Stock net income for the last quarter?

MaxCyte, Inc. - Common Stock reported net income of -4.75 M for the last quarter. The previous quarter showed -9.6 M, which means net income changed by +50.50%.

How many employees does MaxCyte, Inc. - Common Stock have?

As of the latest available data, MaxCyte, Inc. - Common Stock has 91 employees. Workforce size can provide additional context about the company's scale and operations.

What is MaxCyte, Inc. - Common Stock EBITDA?

MaxCyte, Inc. - Common Stock EBITDA is -5.14 M, and its EBITDA margin is -53.24%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy MaxCyte, Inc. - Common Stock stock?

You can buy MaxCyte, Inc. - Common Stock (MXCT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in MaxCyte, Inc. - Common Stock stock?

Investing in MaxCyte, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MXCT chart and related analysis on metatrader.com as part of your research.

News